Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 1;7(10):e2440577.
doi: 10.1001/jamanetworkopen.2024.40577.

Cardiovascular Risk Scores and Migraine Status

Affiliations

Cardiovascular Risk Scores and Migraine Status

Linda Al-Hassany et al. JAMA Netw Open. .

Abstract

Importance: A previous cohort study in the US found that women with higher cardiovascular risk were more likely to have a history of migraine but less likely to have active migraine. Extrapolating these results to men and European individuals is crucial to understanding the complex association between migraine activity status and vascular health in other populations.

Objective: To evaluate the association pattern between a cardiovascular risk score, the most recent European version of the Systematic Coronary Risk Evaluation 2 (SCORE2) risk estimation system, and migraine activity status in Dutch men and women.

Design, setting, and participants: The prospective population-based Lifelines cohort consists of community-dwelling adults residing in the northern part of the Netherlands. Individuals with a terminal illness, incapacitated individuals, including those with a severe mental illness, or who were unable to visit their general practitioner or complete the questionnaires were excluded from participation within Lifelines. Participants whose data on the cardiovascular risk scores and migraine status were complete were included in the analysis. Data on baseline characteristics were collected between November 1, 2006, to December 31, 2014. Cross-sectional and follow-up analyses were conducted within the prospective cohort. Questionnaires were sent approximately every 1.5 to 2.5 years, and the last self-reported migraine assessment took place between October 1, 2019, and January 31, 2021. Data were analyzed from March 1, 2022, to August 16, 2024.

Exposures: The SCORE2 is a sex-specific European cardiovascular risk score that includes age, cholesterol levels, smoking status, diabetes, and systolic blood pressure.

Main outcomes and measures: The primary outcome was the association pattern between cardiovascular risk scores and migraine activity status. SCORE2 risk scores were measured once at baseline; groups of the SCORE2 (<1.0%, 1.0% to <2.5%, 2.5% to <5.0%, 5.0% to <7.5%, 7.5% to <10.0%, and ≥10.0%) were created based on the sum of points of individual risk factors. Migraine activity status was assessed using self-reported questionnaires and classified as (1) prevalent (ie, migraine at baseline), (2) incident (ie, no migraine at baseline but migraine in ≥1 follow-up), and (3) none. To evaluate the influence of age, we conducted stratified analyses of the SCORE2 by age categories (<40, 40-49, and ≥50 years).

Results: The total study population consisted of 140 915 individuals at baseline with a mean (SD) age of 44.4 (12.7) years, of whom 58.5% were women. In total, 25 915 individuals (18.4% of the total population) had prevalent migraine and 2224 (1.9% of the 115 000 without prevalent migraine) had incident migraine. The odds of having prevalent and incident migraine, compared with individuals with a SCORE2 category of less than 1.0%, varied and decreased with increasing SCORE2 categories, with odds ratios (ORs) for prevalent migraine ranging from 0.93 (95% CI, 0.90-0.96) for a SCORE2 category of 1.0% to less than 2.5% to 0.43 (95% CI, 0.39-0.48) for a SCORE2 category of at least 10.0% and, for incident migraine, from 0.63 (95% CI, 0.57-0.69) for a SCORE2 category of 1.0% to less than 2.5% to 0.17 (95% CI, 0.10-0.27) for a SCORE2 category of at least 10.0%. A similar pattern was observed in both sexes but more profound in women. In women, ORs for prevalent migraine ranged from 1.21 (95% CI, 1.16-1.25) to 0.70 (95% CI, 0.58-0.83) (vs 1.19 [95% CI, 1.09-1.29] to 0.84 [95% CI, 0.72-0.99] in men) and, for incident migraine, 0.72 (95% CI, 0.64-0.80) to 0.20 (95% CI, 0.07-0.43) (vs 1.18 [95% CI, 0.92-1.52] to 0.44 [95% CI, 0.22-0.78] in men). Models with incident migraine as the outcome showed lower ORs across the ascending cardiovascular risk score categories. Age stratification suggested that the association between cardiovascular risk scores and migraine activity status were unlikely to be strongly influenced by age.

Conclusions and relevance: In this cohort study of community-dwelling Dutch adults, the odds of having prevalent or incident migraine decreased with increasing cardiovascular risk score categories. These results support the hypothesis that a relatively healthy cardiovascular system increases the probability of having active or developing migraine in the future, especially among women. Sex differences might play a pathophysiological role in the association between migraine activity and vascular health.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Prof MaassenVanDenBrink reported receiving grant funding from Novartis AG, Satsuma Pharmaceuticals Inc, Tonix Pharmaceuticals, Manistee, and Pfizer Inc and receiving speaking and/or advisory board fees from AbbVie Inc, Eli Lilly and Company, Novartis AG, H Lundbeck A/S, Teva Pharmaceutical Industries Ltd, and Pfizer Inc outside the submitted work. Prof Kurth reported receiving grant funding from the German Federal Joint Committee and personal fees from Eli Lilly and Company, Novartis AG, BMJ, and Frontiers Media SA outside the submitted work.

Figures

Figure.
Figure.. Cumulative Estimates of the Probability of Not Having an Incident Migraine
These estimates are stratified by the Systematic Coronary Risk Evaluation 2 (SCORE2) risk category. SCORE2 risk categories range from less than 1.0% (lowest risk) to at least 10.0% (highest risk). Shaded areas represent 95% CIs.

Similar articles

Cited by

  • From Headache to Heart Health: Investigating the Migraine-Cardiovascular Disease Connection.
    Tana C, Onan D, Messina R, Waliszewska-Prosół M, Garcia-Azorin D, Leal-Vega L, Coco-Martin MB, Ornello R, Raffaelli B, Souza MNP, Wells-Gatnik W, Martelletti P. Tana C, et al. Neurol Ther. 2025 Aug;14(4):1229-1268. doi: 10.1007/s40120-025-00785-z. Epub 2025 Jun 20. Neurol Ther. 2025. PMID: 40540097 Free PMC article. Review.
  • Migraine with and without aura-two distinct entities? A narrative review.
    Grodzka O, Dzagoevi K, Rees T, Cabral G, Chądzyński P, Di Antonio S, Sochań P, MaassenVanDenBrink A, Lampl C; European Headache Federation School of Advanced Studies (EHF-SAS). Grodzka O, et al. J Headache Pain. 2025 Apr 14;26(1):77. doi: 10.1186/s10194-025-01998-1. J Headache Pain. 2025. PMID: 40229683 Free PMC article. Review.
  • Concomitant anti-CGRP and immunomodulatory treatments in patients with migraine: towards integrated management strategies.
    García-Castillo MC, Sierra-Mencía Á, Caronna E, Toledo-Alfocea D, Jaimes A, Urtiaga S, Casas-Limón J, Muñoz-Vendrell A, Santos-Lasaosa S, García Martín V, Martín Ávila G, Polanco M, Villar-Martínez MD, Trevino-Peinado C, Rubio-Flores L, Sánchez-Soblechero A, Portocarrero Sánchez L, Luque-Buzo E, Lozano-Ros A, Gago-Veiga AB, Díaz-De-Terán J, Recio García A, Canales Rodríguez J, Gómez García A, González Salaices M, Campoy S, Mínguez-Olaondo A, Maniataki S, González-Quintanilla V, Porta-Etessam J, Cuadrado ML, Guerrero Peral ÁL, Pozo-Rosich P, Rodríguez-Vico J, Huerta-Villanueva M, Pascual J, Goadsby PJ, Gonzalez-Martinez A. García-Castillo MC, et al. J Neurol. 2025 Jun 3;272(6):443. doi: 10.1007/s00415-025-13177-y. J Neurol. 2025. PMID: 40461909 Free PMC article.

References

    1. Headache Classification Committee of the International Headache Society . The International Classification of Headache Disorders. 3rd ed. Cephalalgia; 2018;38(1):1-211. - PubMed
    1. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators . Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211-1259. doi:10.1016/S0140-6736(17)32154-2 - DOI - PMC - PubMed
    1. GBD 2016 Neurology Collaborators . Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459-480. doi:10.1016/S1474-4422(18)30499-X - DOI - PMC - PubMed
    1. Mahmoud AN, Mentias A, Elgendy AY, et al. . Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects. BMJ Open. 2018;8(3):e020498. doi:10.1136/bmjopen-2017-020498 - DOI - PMC - PubMed
    1. Ng CYH, Tan BYQ, Teo YN, et al. . Myocardial infarction, stroke and cardiovascular mortality among migraine patients: a systematic review and meta-analysis. J Neurol. 2022;269(5):2346-2358. doi:10.1007/s00415-021-10930-x - DOI - PubMed

Publication types